| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase LC POSITIVE ION MODE | 1A_91_1_326 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_91_1_329 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_92_1_327 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_92_1_330 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_93_1_328 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 1A_93_1_331 | Treatment:Control | AU |
| Reversed phase LC POSITIVE ION MODE | 3a_-2_93_1_336 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a-71_91_1_384 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a_-7_92_1_382 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a_-7_93_1_386 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a-8_91_1_385 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a_-8_92_1_383 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3a_-8_93_1_387 | Treatment:TRASTUZUMAB | AU |
| Reversed phase LC POSITIVE ION MODE | 3ar_91_1_333 | Treatment:TRASTUZUMAB | AU |
Return to study ST002318 main page
Download data matrix(Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with trastuzumab Reversed phase LC POSITIVE ION MODE)
- Metabolomics Workbench
|